Sponsored by the University of Maryland School of Medicine

Department of Emergency Medicine

EMERGENCY MEDICINE GRAND ROUNDS AND CONFERENCE SERIES

Wednesday 11/8/17
10:45 AM

SHIRA KANSAS - BUGS & DRUGS


Speaker:

David Talan, MD
Professor in Residence, Departments of Emergency Medicine and Medicine, Division of Infectious Diseases, The David Geffen School of Medicine at UCLA


Learning Objectives:
Upon completion of this activity, participants should be able to:
To allow the participant to effectively treat infections in the ED by understanding the latest medical evidence regarding:

1. Concepts of empiric decision making

2. Emerging trends in antibiotic resistance

3. Antibiotic strategies to minimize avoidable hospitalizations.

Disclosure:
It is the policy of the University of Maryland School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, all persons in a position to control the educational content of this regularly scheduled series must disclose any relevant financial relationships they have with commercial interests. Any identified conflicts of interest must be resolved prior to speaker's presentation.

The organizers listed below have disclosed no relevant financial relationships with commercial interests: Gentry Wilkerson MD, Sarah Dubbs MD, Michael Bond MD, Semhar Tewelde MD, Janae Yates

The individuals listed below have disclosed relevant financial relationships with commercial interests: NONE

The lecturer, David Talan, MD, has no relevant financial relationships to disclose.

University of Maryland School of Medicine Office of CME staff members have disclosed no relevant financial relationships.

Accreditation:
The University of Maryland School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:
The University of Maryland School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Discussion of Off-Label or Investigational Uses or Products:

Presentations in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. The audience is advised to consult the full prescribing information of all drugs or devices prior to use.